Eukarion Inc entered the industry of Commercial Medical Research in 1991 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Bernard Malfroy-Camine by calling (781) 275-0424 during business hours. You can also write to the business’ Single Location at 6 Alfred Circle Front, Bedford, Massachusetts MA 01730. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Eukarion Inc |
Representative: | Bernard Malfroy-Camine |
Place of Business: | 6 Alfred Circle Front, Bedford, MA 01730 |
Contact Number: | (781) 275-0424 |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1991 |
Income/Year: | $1.000.000 to $2.499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Eukarion Inc is a company operating from Middlesex, Massachusetts providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1991 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Eukarion Inc has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Bernard Malfroy-Camine at (781) 275-0424 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 6 Alfred Circle Front in Bedford, Massachusetts 01730 and can be engaged online through the company website at , the company Twitter , and Facebook page .